Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Ovid Therapeutics (OVID) Receiveable Turnover data is not available for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$0.39M |
|
$-52.34M |
|
-- |
|
$0.39M |
|
$59.67M |
|
$-59.28M |
|
$6.94M |
|
$-52.34M |
|
$-52.34M |
|
$-52.34M |
|
$-52.34M |
|
$-52.34M |
|
$-52.34M |
|
$-59.28M |
|
$-57.68M |
|
70.58M |
|
70.58M |
|
$-0.74 |
|
$-0.74 |
|
| Balance Sheet Financials | |
$109.60M |
|
$0.77M |
|
$34.43M |
|
$144.03M |
|
$11.47M |
|
$14.76M |
|
$44.76M |
|
$56.23M |
|
$87.80M |
|
$87.80M |
|
$87.80M |
|
70.69M |
|
| Cash Flow Statement Financials | |
$-45.78M |
|
$-2.58M |
|
$30.54M |
|
$46.80M |
|
$28.97M |
|
$-17.83M |
|
$7.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.55 |
|
-- |
|
-- |
|
0.14 |
|
0.18 |
|
100.00% |
|
-15134.60% |
|
-15134.60% |
|
-14726.99% |
|
-13362.17% |
|
-13362.17% |
|
$-45.82M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
|
Receiveable Turnover |
-- |
-- |
|
-59.61% |
|
-59.61% |
|
-36.34% |
|
-51.04% |
|
$1.24 |
|
$-0.65 |
|
$-0.65 |
|